The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Mutual exclusivity analysis identifies oncogenic network modules
Open accessAbstract
Although individual tumors of the same clinical type have surprisingly diverse genomic alterations, these events tend to occur in a limited number of pathways, and alterations that affect the same pathway tend to not co-occur in the same patient. While pathway analysis has been a powerful tool in cancer genomics, our knowledge of oncogenic pathway modules is incomplete. To systematically identify such modules, we have developed a novel method, Mutual Exclusivity Modules in cancer (MEMo). The method uses correlation analysis and statistical tests to identify network modules by three criteria: (1) Member genes are recurrently altered across a set of tumor samples; (2) member genes are known to or are likely to participate in the same biological process; and (3) alteration events within the modules are mutually exclusive. Applied to data from the Cancer Genome Atlas (TCGA), the method identifies the principal known altered modules in glioblastoma (GBM) and highlights the striking mutual exclusivity of genomic alterations in the PI(3)K, p53, and Rb pathways. In serous ovarian cancer, we make the novel observation that inactivation of BRCA1 and BRCA2 is mutually exclusive of amplification of CCNE1 and inactivation of RB1 , suggesting distinct alternative causes of genomic instability in this cancer type; and, we identify RBBP8 as a candidate oncogene involved in Rb-mediated cell cycle control. When applied to any cancer genomics data set, the algorithm can nominate oncogenic alterations that have a particularly strong selective effect and may also be useful in the design of therapeutic combinations in cases where mutual exclusivity reflects synthetic lethality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
KEGG for linking genomes to life and the environment
Kanehisa, M., Araki, M., Goto, S., Hattori, M., Hirakawa, M., Itoh, M., Katayama, T., Kawashima, S., Okuda, S., Tokimatsu, T., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm882 · Cited by 6,782
Network medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034
From molecular to modular cell biology.
Hartwell, L. H., Hopfield, J. J., Leibler, S., & Murray, A. W. (1999) · Nature · doi:10.1038/35011540 · Cited by 3,632
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,449
Human Protein Reference Database--2009 update
Keshava Prasad, T. S., Goel, R., Kandasamy, K., Keerthikumar, S., Kumar, S., Mathivanan, S., Telikicherla, D., Raju, R., Shafreen, B., Venugopal, A., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn892 · Cited by 3,234
Patterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustment.
Martin, M. A., Westfall, P. H., & Young, S. S. (1994) · Biometrics · doi:10.2307/2533464 · Cited by 1,699
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
Hallmarks of 'BRCAness' in sporadic cancers
Turner, N., Tutt, A., & Ashworth, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1457 · Cited by 1,657
The link prediction problem for social networks
Liben-Nowell, D., & Kleinberg, J. (2003) · Proceedings of the twelfth international conference on Information and knowledge management · doi:10.1145/956863.956972 · Cited by 1,612
PID: the Pathway Interaction Database
Schaefer, C. F., Anthony, K., Krupa, S., Buchoff, J., Day, M., Hannay, T., & Buetow, K. H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn653 · Cited by 1,603
Genetic Pathways to Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070011 · Cited by 1,497
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224 · cited 2×
“…signaling pathway) (Sparks et al. 1998), and BRAF and KRAS mutations (both involved in the common RAS/RAF signaling pathway) in colorectal cancer (Rajagopalan et al. 2002); and mutual exclusivity between BRCA1/2 mutations and BRCA1 epigenetic silencing in serous ovarian cancer (The Cancer Genome…”
BackgroundPathway Commons, a web resource for biological pathway data
Cerami, E. G., Gross, B. E., Demir, E., Rodchenkov, I., Babur, O., Anwar, N., Schultz, N., Bader, G. D., & Sander, C. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1039 · Cited by 1,101
Self-citationBeroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J. C., Huang, J. H., Alexander, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710052104 · Cited by 1,075
Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.
Sparks, A. B., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · PubMed · Cited by 1,008
Reactome knowledgebase of human biological pathways and processes
Matthews, L., Gopinath, G., Gillespie, M., Caudy, M., Croft, D., de Bono, B., Garapati, P., Hemish, J., Hermjakob, H., Jassal, B., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn863 · Cited by 873
Vaske, C. J., Benz, S. C., Sanborn, J. Z., Earl, D., Szeto, C., Zhu, J., Haussler, D., & Stuart, J. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq182 · Cited by 786
A human functional protein interaction network and its application to cancer data analysis
Wu, G., Feng, X., & Stein, L. (2010) · Genome Biology · doi:10.1186/gb-2010-11-5-r53 · Cited by 692
Mi, H., Dong, Q., Muruganujan, A., Gaudet, P., Lewis, S., & Thomas, P. D. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1019 · Cited by 609
Predicting disease genes using protein–protein interactions
Oti, M., Snel, B., Huynen, M. A., & Brunner, H. G. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.041376 · Cited by 574
Cyclin E in normal and neoplastic cell cycles
Hwang, H. C., & Clurman, B. E. (2005) · Oncogene · doi:10.1038/sj.onc.1208613 · Cited by 514
Memorial Sloan Kettering Cancer Center
(2015) · The SAGE Encyclopedia of Cancer and Society · doi:10.4135/9781483345758.n370 · Cited by 502
Carter, H., Chen, S., Isik, L., Tyekucheva, S., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., & Karchin, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1133 · Cited by 458
Algorithms for Detecting Significantly Mutated Pathways in Cancer
Vandin, F., Upfal, E., & Raphael, B. J. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0265 · Cited by 430
Yu, X., & Chen, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9478-9486.2004 · Cited by 410
Efficient Detection of Network Motifs
Wernicke, S. (2006) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2006.51 · Cited by 402
Automated Network Analysis Identifies Core Pathways in Glioblastoma
Cerami, E., Demir, E., Schultz, N., Taylor, B. S., & Sander, C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008918 · Cited by 333
Self-citationEtemadmoghadam, D., deFazio, A., Beroukhim, R., Mermel, C., George, J., Getz, G., Tothill, R., Okamoto, A., Raeder, M. B., AOCS Study Group, et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1564 · Cited by 302
On the uniform generation of random graphs with prescribed degree sequences
Milo, R., Kashtan, N., Itzkovitz, S., Newman, M. E. J., & Alon, U. (2003) · arXiv · doi:10.48550/arxiv.cond-mat/0312028 · Cited by 281
A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
Stecca, B., & Ruiz i Altaba, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.16 · Cited by 233
Nakayama, N., Nakayama, K., Shamima, Y., Ishikawa, M., Katagiri, A., Iida, K., & Miyazaki, K. (2010) · Cancer · doi:10.1002/cncr.24987 · Cited by 201
A Network Model of a Cooperative Genetic Landscape in Brain Tumors
Bredel, M., Scholtens, D. M., Harsh, G. R., Bredel, C., Chandler, J. P., Renfrow, J. J., Yadav, A. K., Vogel, H., Scheck, A. C., Tibshirani, R., et al. (2009) · JAMA · doi:10.1001/jama.2009.997 · Cited by 192
Functional Copy-Number Alterations in Cancer
Taylor, B. S., Barretina, J., Socci, N. D., DeCarolis, P., Ladanyi, M., Meyerson, M., Singer, S., & Sander, C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003179 · Cited by 170
Self-citationCanPredict: a computational tool for predicting cancer-associated missense mutations
Kaminker, J. S., Zhang, Y., Watanabe, C., & Zhang, Z. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm405 · Cited by 146
Chen, P., Liu, F., Cai, S., Lin, X., Li, A., Chen, Y., Gu, B., Lee, E. Y.-H. P., & Lee, W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.9.3535-3542.2005 · Cited by 132
Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers"
Getz, G. A., Höfling, H., Mesirov, J. P., Golub, T. R., Meyerson, M. M., Tibshirani, R. J., & Lander, E. S. (2007) · Science · doi:10.1126/science.1138764 · Cited by 130
Identification of rare cancer driver mutations by network reconstructionPreprint
Torkamani, A., & Schork, N. J. (2009) · Genome Research · doi:10.1101/gr.092833.109 · Cited by 115
Etemadmoghadam, D., George, J., Cowin, P. A., Cullinane, C. M., Kansara, M., Chenevix‐Trench, G., Gorringe, K. L., Smyth, G. K., & Bowtell, D. D. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015498 · Cited by 106
Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
Gorringe, K. L., George, J., Anglesio, M. S., Ramakrishna, M., Etemadmoghadam, D., Cowin, P. A., Sridhar, A., Williams, L. H., Boyle, S. E., Yanaihara, N., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011408 · Cited by 89
Patient-oriented gene set analysis for cancer mutation data
Boca, S. M., Kinzler, K. W., Velculescu, V. E., Vogelstein, B., & Parmigiani, G. (2010) · Genome biology · doi:10.1186/gb-2010-11-11-r112 · Cited by 77
Defining the blueprint of the cancer genome
Velculescu, V. E. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn096 · Cited by 59
Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers"
Forrest, W. F., & Cavet, G. (2007) · Science · doi:10.1126/science.1138179 · Cited by 58
CtIP Activates Its Own and Cyclin D1 Promoters via the E2F/RB Pathway during G 1 /S Progression
Liu, F., & Lee, W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3124-3134.2006 · Cited by 58
p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1
Ng, C.-C., Arakawa, H., Fukuda, S., Kondoh, H., & Nakamura, Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206586 · Cited by 54
Cowin, P. A., Anglesio, M. S., Etemadmoghadam, D., & Bowtell, D. D. L. (2010) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082509-141536 · Cited by 48
Algorithms for Detecting Significantly Mutated Pathways in Cancer
Vandin, F., Upfal, E., & Raphael, B. J. (2010) · Lecture notes in computer science · doi:10.1007/978-3-642-12683-3_33 · Cited by 37
Detection of Activity Centers in Cellular Pathways Using Transcript Profiling
Pradines, J., Rudolph‐Owen, L. A., Hunter, J., Leroy, P. J., Cary, M. P., Coopersmith, R., Dančík, V., Eltsefon, Y., Farutin, V., Leroy, C., et al. (2004) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-200025678 · Cited by 13
Self-citation
Cited by
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Metadata
- Authors
- Ciriello, G., Cerami, E., Sander, C., & Schultz, N.
- Venue
- Genome Research
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-09-09
- Volume
- 22
- Issue
- 2
- Pages
- 398-406
- ISSN
- 1088-9051 (ISSN-L)
- OpenAlex
- W2144940507
- Cited by
- 675
- References
- 53
- Type
- posted content
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.